Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder.
ADD, or attention defecit disorder, is a neurological disorder that causes difficulty focusing, impulsive activity, and sometimes anxiety. Adults with ADD might say some of the following to themselves:
Much more adults suffer through ADD than one might think, but it is hard to identify due to the wide range of symptoms. ADD is especially hard to deal with as an adult because of how it affects their work and home lives. Living with ADD makes it hard to concentrate on specific tasks, which can in turn lead to several job changes, dismal performance at work, and even unemployment at its worst. The biggest and defining symptom of ADD is that those effected suffer from the inability to plan ahead for tasks and take them to completion. Another defining symptom is general restlessness and distractedness.
ADD was once believed to not affect adults; in the 1980s, doctors and clinicians theorized that ADD could remain from childhood to adulthood. The amount of people that suffer from ADD increased by triple the previous amount from 2002 to 2007. In the USA alone, 10 million people experience ADD signs and symptoms. However, almost ¾ of the 10 million affected do not even know that it is ADD. Many adults that experience ADD symptoms are not able to recognize the signs because they were never diagnosed, especially when younger. When these same people start going through the trials and tribulations of adulthood, the stress of it all makes their ADD symptoms much more recognizable.
Are any of these symptoms sounding familiar to you? Is it hard for you to maintain focus and concentration? Is your work or social life suffering due to constant distraction? You are not alone. Reach out to us at the Institute for Advanced Medical Research at 770-817-9200 to learn about what treatment options are out there for you.
You Might Also Enjoy...
Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder.
Pain can be depressing, and depression creates and exacerbates pain. This cycle can be a dangerous one. In fact, people afflicted by chronic pain are three times more likely to develop psychiatric disorders (most often anxiety or mood disorders).
Depression is a mental disorder that both men and women struggle with. However, in the case of men, the disorder can look very differently that it looks in women.
Anyone that has had Chickenpox, even if it was all the way back in childhood, now lives with the risk of experiencing Shingles when they enter their later years. And what does that have to do with Fibromyalgia?!
If you or a loved one are still struggling with depression even on medication, you are not the only one!
Fibromyalgia is painful, difficult to diagnose and has limited treatment options. But there are always new drugs being developed! #Fibro #FibroATL #FibroAlpharetta #FibroOptions